During the past decade, China National Center for Cardiovascular Diseases conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "China National Center for Cardiovascular Diseases" #1 collaborator was "First Affiliated Hospital, Sun Yat-Sen University" with 3 trials as a collaborator, "Beijing Anzhen Hospital" with 2 trials as a collaborator, "General Hospital of Shenyang Military Region" with 2 trials as a collaborator, "Renmin Hospital of Wuhan University" with 2 trials as a collaborator and "Second Affiliated Hospital of Nanchang University" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "China National Center for Cardiovascular Diseases" are "Coronary Artery Bypass Grafting" (2 trials), "Persistent Atrial Fibrillation" (2 trials), "Ventricular Arrythmia" (2 trials), "Appropriateness" (1 trials) and "Cardioneuroablation" (1 trials). Many other conditions were trialed in "China National Center for Cardiovascular Diseases" in a lesser frequency.

Most popular intervention types in "China National Center for Cardiovascular Diseases" are "Procedure" (4 trials), "Behavioral" (3 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "cardiac ganglion plexus ablation(cardioneuroablation)" (2 trials), "APP intervention" (1 trials), "Additional LAAW linear ablation" (1 trials), "Hybrid ablation" (1 trials) and "Permanent pacemaker implantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "China National Center for Cardiovascular Diseases" are 11 trials for "All" genders.

Currently, there are NaN active trials in "China National Center for Cardiovascular Diseases". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in China National Center for Cardiovascular Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in China National Center for Cardiovascular Diseases, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".